Sobre HAY

HAY pharma firmly believes that numerous effective medicines can be produced from the natural phytomedicine cannabis. Phytocannabinoids such as THC and CBD, with their high therapeutic potential, should be available to all patients worldwide without restrictions. HAY pharma intensively supports the research of the more than 400 ingredients of Cannabis Sativa L., and thus helps to better understand the medicinal mechanisms of cannabinoids, terpenes and flavonoids.

HAY pharma sells all of its medicines, which are produced exclusively according to the highest pharmaceutical quality standards, globally. HAY’s self-imposed, additional quality requirements internally as well as externally are particularly important to us: from cultivation to production, from integrated distribution to logistics – we set the bar higher than the GDP and GMP guidelines or than many competitors at every step of the value chain.